Skip to main content

Beating the Blues with Exercise...

Exercise as an antidote to depression and anxiety is 
not a new concept.




Exercise as an antidote to depression and anxiety is not a new concept. In the 18th century Scotland, doctors in mental hospitals prescribed heavy farm chores as "the best medicine" for their patients and documented marked improvements in mood and behavior. Now scientists are studying the link between exercise and mood changes at close range and coming up with some fascinating results.

One expert in the field says "exercise is clearly associated with mental-health benefits." And moderate exercisers show lowered blood-pressure levels and a resultant positive mood. The key is moderate exercise, performed a minimum of 30 minutes, three or four times a week. Brisk walking, swimming, lifting weights, and bicycling - all achieve good results.

People who exercise regularly, even at something as simple as walking or bicycling, are more flexible. They experience less stress on the muscles and joints when they do bend down the wrong way. Conditioned muscles recover faster, too. It's the couch potato who hauls himself erect one Saturday afternoon to rake the leaves or shovel snow who has trouble

Popular posts from this blog

You Will Never Thought That Knowing What Is Health Insurance Could Be So Beneficial!

some useful vegetable for Breast Cancer prevention

Broccoli C auliflower Brussel Sprouts Spinach Coliards Tomatoes Kale Cabbage Carrots Have more sex.....Prevention Cancer  

FDA Panel Votes to Approve 'Female Viagra' With Conditions After Third Hearing

   By GILLIAN MOHNEY and LANA ZAK via Good Morning America An expert panel for the U.S. Food and Drug Administration voted today to approve a drug that has been dubbed the "female Viagra" after two previous attempts failed to gain approval. The FDA is set to make a final decision in August, and while the agency generally follows to the panelists' vote, it is not bound to adhere to it. Medical experts from the FDA examined the evidence on the effectiveness of the drug flibanserin, designed to help per-menopausal women with Hypo active Sexual Desire Disorder (HSDD). This is the third time the drug has been presented to the FDA, after previous attempts to get the drug approved failed in part due to the agency having concerns about whether its benefits outweighed the risks. A mother and her daughter were among those to offer emotional testimony to the FDA panel today. The mother, Barbara, talked about how her relationships with her husband and family became st